GB201516183D0 - Novel pharmaceutical composition - Google Patents
Novel pharmaceutical compositionInfo
- Publication number
- GB201516183D0 GB201516183D0 GBGB1516183.9A GB201516183A GB201516183D0 GB 201516183 D0 GB201516183 D0 GB 201516183D0 GB 201516183 A GB201516183 A GB 201516183A GB 201516183 D0 GB201516183 D0 GB 201516183D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- novel pharmaceutical
- novel
- composition
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1516183.9A GB201516183D0 (en) | 2015-09-14 | 2015-09-14 | Novel pharmaceutical composition |
PCT/GB2016/052833 WO2017046581A1 (en) | 2015-09-14 | 2016-09-14 | Composition comprising cav2.2 calcium channel blocker and opioid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1516183.9A GB201516183D0 (en) | 2015-09-14 | 2015-09-14 | Novel pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201516183D0 true GB201516183D0 (en) | 2015-10-28 |
Family
ID=54363082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1516183.9A Ceased GB201516183D0 (en) | 2015-09-14 | 2015-09-14 | Novel pharmaceutical composition |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201516183D0 (en) |
WO (1) | WO2017046581A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008534630A (en) * | 2005-04-08 | 2008-08-28 | ニューロメッド ファーマシューティカルズ リミテッド | Method of combination therapy including N-type calcium channel blockers for pain relief |
GB0813142D0 (en) * | 2008-07-17 | 2008-08-27 | Glaxo Group Ltd | Novel compounds |
-
2015
- 2015-09-14 GB GBGB1516183.9A patent/GB201516183D0/en not_active Ceased
-
2016
- 2016-09-14 WO PCT/GB2016/052833 patent/WO2017046581A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2017046581A1 (en) | 2017-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL265360A (en) | Pharmaceutical composition | |
IL265260B (en) | Pharmaceutical composition | |
GB201409471D0 (en) | Pharmaceutical composition | |
IL262654A (en) | Pharmaceutical composition | |
GB201409488D0 (en) | Pharmaceutical composition | |
IL265349A (en) | Pharmaceutical composition | |
GB201409485D0 (en) | Pharmaceutical composition | |
SI3278801T1 (en) | Pharmaceutical composition containing mirabegron | |
GB201521462D0 (en) | Pharmaceutical composition | |
GB201615917D0 (en) | Pharmaceutical composition | |
GB201515310D0 (en) | Pharmaceutical composition | |
HK1245073A1 (en) | Pharmaceutical compositions | |
PL3454838T3 (en) | Pharmaceutical composition | |
GB201520862D0 (en) | Pharmaceutical composition | |
GB201615914D0 (en) | Pharmaceutical composition | |
GB201615910D0 (en) | Pharmaceutical composition | |
SI3089740T1 (en) | Pharmaceutical composition | |
IL265436B (en) | Pharmaceutical composition | |
GB201620519D0 (en) | Pharmaceutical composition | |
SG10201504332VA (en) | Pharmaceutical Composition | |
IL265428A (en) | Pharmaceutical composition | |
PT3476391T (en) | Pharmaceutical composition | |
GB201620516D0 (en) | Pharmaceutical composition | |
GB201620517D0 (en) | Pharmaceutical composition | |
GB201620513D0 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |